SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- December 19, 2006 -- Holmes Biopharma, Inc. (PINK SHEETS: HLMB) announces that sales efforts for its Phase 1 clinic in Omaha, Nebraska continue to show strong growth. The company had revenue of approximately $200,000 in December 2006, and plans to reach the $2 million mark on signed contracts by February 2007.
